SYNthesis Med Chem is a cutting-edge player in the chemistry CRO market. Founded in 2007, this Australian-owned company offers a range of services in the field of drug discovery. With laboratory facilities in Shanghai, China, and offices in Australia, the US, and the UK, SYNthesis provides global support to clients from biotech, big pharma, and academia.

Led by a team of experienced drug discovery professionals, SYNthesis specializes in targets such as Kinases, GPCRs, and epigenetic targets. Their expertise in medicinal and synthetic chemistry allows them to offer integrated drug discovery services, single compound synthesis, and a variety of catalogue products. Committed to client satisfaction, SYNthesis achieves an outstanding return rate, with several clients collaborating on multiple target classes.

Trust SYNthesis Med Chem for your medicinal chemistry needs